Literature DB >> 16415178

The microtubule binding drug laulimalide inhibits vascular endothelial growth factor-induced human endothelial cell migration and is synergistic when combined with docetaxel (taxotere).

Haiyan Lu1, Janice Murtagh, Edward L Schwartz.   

Abstract

Laulimalide, a natural product from marine sponges, is a microtubule-stabilizing agent that binds to tubulin at a site distinct from that of the taxoids. In the present study, we found that laulimalide inhibited human umbilical vein endothelial cell (HUVEC) tubule formation and vascular endothelial growth factor (VEGF)-induced HUVEC migration, key components of the angiogenic process. These occurred at concentrations substantially lower than that which inhibited HUVEC proliferation. When combined, laulimalide and docetaxel (Taxotere) synergistically inhibited migration and tubule formation, but their combined effect on proliferation was antagonistic. Possible mechanism(s) by which laulimalide inhibited VEGF-induced HUVEC migration were explored. Similar to docetaxel, laulimalide had no effect on the VEGF-induced tyrosine phosphorylation of the VEGF receptor Flk-1/KDR (VEGFR-2). Low concentrations of laulimalide substantially blocked subsequent VEGFR-2 downstream events, as did docetaxel, including the phosphorylation of the Tyr397 and Tyr407 residues of focal adhesion kinase (FAK), the association of VEGFR-2 with FAK and Hsp90, and the Tyr31 phosphorylation of paxillin. Laulimalide inhibited integrin activation; however, compared with docetaxel, it had a weaker inhibitory effect on the VEGF-induced association of VEGFR-2 with the alpha5beta1 integrin. Compared with docetaxel, laulimalide more potently caused a reduction in the constitutive levels (i.e., in the absence of VEGF) of phosphorylated paxillin and more potently inhibited the association of RhoA with the alpha5beta1 integrin. In conclusion, although both docetaxel and laulimalide inhibited integrin-associated signaling pathways that mediated VEGF-induced cell migration, their actions on the signaling cascade seemed not to be identical. These complementary actions could account for their synergistic effects on HUVEC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16415178     DOI: 10.1124/mol.105.019075

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  19 in total

1.  Enterolobium contortisiliquum trypsin inhibitor (EcTI), a plant proteinase inhibitor, decreases in vitro cell adhesion and invasion by inhibition of Src protein-focal adhesion kinase (FAK) signaling pathways.

Authors:  Cláudia Alessandra Andrade de Paula; Vivien Jane Coulson-Thomas; Joana Gasperazzo Ferreira; Paloma Korehisa Maza; Erika Suzuki; Adriana Miti Nakahata; Helena Bonciani Nader; Misako Uemura Sampaio; Maria Luiza V Oliva
Journal:  J Biol Chem       Date:  2011-10-28       Impact factor: 5.157

Review 2.  Antivascular actions of microtubule-binding drugs.

Authors:  Edward L Schwartz
Journal:  Clin Cancer Res       Date:  2009-04-07       Impact factor: 12.531

Review 3.  Role of the cytoskeleton in formation and maintenance of angiogenic sprouts.

Authors:  Kayla J Bayless; Greg A Johnson
Journal:  J Vasc Res       Date:  2011-04-04       Impact factor: 1.934

Review 4.  Building branched tissue structures: from single cell guidance to coordinated construction.

Authors:  James W Spurlin; Celeste M Nelson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-05-19       Impact factor: 6.237

5.  Inhibition of human vascular endothelial cell migration and capillary-like tube formation by the microtubule-stabilizing agent peloruside A.

Authors:  Ariane Chan; A Jonathan Singh; Peter T Northcote; John H Miller
Journal:  Invest New Drugs       Date:  2015-03-31       Impact factor: 3.850

6.  Nitrotyrosine impairs angiogenesis and uncouples eNOS activity of pulmonary artery endothelial cells isolated from developing sheep lungs.

Authors:  Ru-Jeng Teng; Tzong-Jin Wu; C Gaston Bisig; Annie Eis; Kirkwood A Pritchard; Girija G Konduri
Journal:  Pediatr Res       Date:  2011-02       Impact factor: 3.756

7.  Function-oriented synthesis: biological evaluation of laulimalide analogues derived from a last step cross metathesis diversification strategy.

Authors:  Susan L Mooberry; Michael K Hilinski; Erin A Clark; Paul A Wender
Journal:  Mol Pharm       Date:  2008-07-29       Impact factor: 4.939

8.  Interference with endothelial cell function by JG-03-14, an agent that binds to the colchicine site on microtubules.

Authors:  Nava Dalyot-Herman; Fernando Delgado-Lopez; David A Gewirtz; John T Gupton; Edward L Schwartz
Journal:  Biochem Pharmacol       Date:  2009-07-01       Impact factor: 5.858

Review 9.  Microtubule dynamics as a target in oncology.

Authors:  April L Risinger; Francis J Giles; Susan L Mooberry
Journal:  Cancer Treat Rev       Date:  2008-12-30       Impact factor: 12.111

10.  Visualization of integrin molecules by fluorescence imaging and techniques.

Authors:  Chen Cai; Hao Sun; Liang Hu; Zhichao Fan
Journal:  Biocell       Date:  2021-02-19       Impact factor: 1.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.